The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
R Bai, Y Li, L Jian, Y Yang, L Zhao, M Wei - Molecular Cancer, 2022 - Springer
Given that hypoxia is a persistent physiological feature of many different solid tumors and a
key driver for cancer malignancy, it is thought to be a major target in cancer treatment …
key driver for cancer malignancy, it is thought to be a major target in cancer treatment …
Tumor angiogenesis and anti-angiogenic strategies for cancer treatment
Angiogenesis is the process through which novel blood vessels are formed from pre-existing
ones and it is involved in both physiological and pathological processes of the body …
ones and it is involved in both physiological and pathological processes of the body …
Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy
Self-assembled peptides and proteins possess tremendous potential as targeted drug
delivery systems and key applications of these well-defined nanostructures reside in anti …
delivery systems and key applications of these well-defined nanostructures reside in anti …
Emerging role of tumor cell plasticity in modifying therapeutic response
Resistance to cancer therapy is a major barrier to cancer management. Conventional views
have proposed that acquisition of resistance may result from genetic mutations. However …
have proposed that acquisition of resistance may result from genetic mutations. However …
The tumor microenvironment in tumorigenesis and therapy resistance revisited
Simple Summary Tumors are not masses of cancer cells alone but made up of cancer cells,
other cells including fibroblasts, macrophages, endothelial cells, as well as secreted factors …
other cells including fibroblasts, macrophages, endothelial cells, as well as secreted factors …
Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
Y Jiang, H Zhan - Cancer letters, 2020 - Elsevier
Immune checkpoint blockage has been considered a breakthrough in cancer treatment,
achieving encouraging anti-tumor effects in some advanced solid malignancies. However …
achieving encouraging anti-tumor effects in some advanced solid malignancies. However …
Immune escape: A critical hallmark in solid tumors
K Mortezaee - Life sciences, 2020 - Elsevier
Incapacitated immune system is a characteristic hallmark of solid tumors. Immune system
within a tumor undergoes an imbalance in cellular dispersion and functionality. Effector cells …
within a tumor undergoes an imbalance in cellular dispersion and functionality. Effector cells …
The role of tumor-stroma interactions in drug resistance within tumor microenvironment
Y Ni, X Zhou, J Yang, H Shi, H Li, X Zhao… - Frontiers in cell and …, 2021 - frontiersin.org
Cancer cells resistance to various therapies remains to be a key challenge nowadays. For a
long time, scientists focused on tumor cells themselves for the mechanisms of acquired drug …
long time, scientists focused on tumor cells themselves for the mechanisms of acquired drug …
Roles of extracellular HSPs as biomarkers in immune surveillance and immune evasion
Extracellular heat shock proteins (ex-HSPs) have been found in exosomes, oncosomes,
membrane surfaces, as well as free HSP in cancer and various pathological conditions, also …
membrane surfaces, as well as free HSP in cancer and various pathological conditions, also …
Novel drugs with high efficacy against tumor angiogenesis
S Qi, S Deng, Z Lian, K Yu - International Journal of Molecular Sciences, 2022 - mdpi.com
Angiogenesis is involved in physiological and pathological processes in the body. Tumor
angiogenesis is a key factor associated with tumor growth, progression, and metastasis …
angiogenesis is a key factor associated with tumor growth, progression, and metastasis …